Chinese scientists recently performed a comprehensive metabonomic analysis to reveal potential mechanisms of berberine action in the treatment of patients with type 2 diabetes and dyslipidemia. Berberine is an alkaloid with a...

    • Please note: The rest of this article is only available to subscribers of the Journal of Chinese medicine. Please subscribe now.

Categories: Herb research, Diabetes, Skin / dermatology

Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now